DK3297651T3 - Synergistisk kombination af neuronale levedygtighedsfaktorer og anvendelser deraf - Google Patents
Synergistisk kombination af neuronale levedygtighedsfaktorer og anvendelser deraf Download PDFInfo
- Publication number
- DK3297651T3 DK3297651T3 DK16724409.4T DK16724409T DK3297651T3 DK 3297651 T3 DK3297651 T3 DK 3297651T3 DK 16724409 T DK16724409 T DK 16724409T DK 3297651 T3 DK3297651 T3 DK 3297651T3
- Authority
- DK
- Denmark
- Prior art keywords
- liveless
- neuronal
- factors
- applications
- synergistic combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14171—Demonstrated in vivo effect
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2015/000967 WO2016185242A1 (en) | 2015-05-21 | 2015-05-21 | Synergistic combination of neuronal viability factors and uses thereof |
| PCT/EP2016/061488 WO2016185037A1 (en) | 2015-05-21 | 2016-05-20 | Synergistic combination of neuronal viability factors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3297651T3 true DK3297651T3 (da) | 2020-05-25 |
Family
ID=54361112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16724409.4T DK3297651T3 (da) | 2015-05-21 | 2016-05-20 | Synergistisk kombination af neuronale levedygtighedsfaktorer og anvendelser deraf |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10668129B2 (da) |
| EP (1) | EP3297651B1 (da) |
| JP (1) | JP6684343B2 (da) |
| CA (1) | CA2986630C (da) |
| DK (1) | DK3297651T3 (da) |
| ES (1) | ES2792905T3 (da) |
| IL (1) | IL255816B (da) |
| WO (2) | WO2016185242A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2027889A1 (en) * | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New neuronal viability factor and use thereof |
| WO2017120294A1 (en) | 2016-01-05 | 2017-07-13 | The Trustees Of The University Of Pennsylvania | Methods and compositions for treatment of ocular disorders and blinding diseases |
| DK3728610T3 (da) * | 2017-12-22 | 2023-08-07 | Sparingvision | Konstrukter omfattende neuronale viabilitetsfaktorer og anvendelser heraf |
| US20210338773A1 (en) | 2018-10-17 | 2021-11-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for treating retinal degeneration disease by administering nucleolin polynucleotide or polypeptide |
| CN113260704B (zh) * | 2019-12-09 | 2022-06-28 | 北京中因科技有限公司 | CYP4V2和RdCVF在制备药物中的用途 |
| WO2022223644A2 (en) | 2021-04-20 | 2022-10-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for treating retinal degenerative disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2823221B1 (fr) * | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| EP2027889A1 (en) | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New neuronal viability factor and use thereof |
| WO2012158757A1 (en) | 2011-05-16 | 2012-11-22 | The Trustees Of The University Of Pennsylvania | Proviral plasmids for production of recombinant adeno-associated virus |
| WO2013063383A2 (en) * | 2011-10-27 | 2013-05-02 | Wellstat Ophthalmics Corporation | Vectors encoding rod-derived cone viability factor |
| ES2796737T3 (es) * | 2012-10-17 | 2020-11-30 | Inst Nat Sante Rech Med | Métodos y composiciones farmacéuticas para el tratamiento de la degeneración macular relacionada con la edad (AMD) |
-
2015
- 2015-05-21 WO PCT/IB2015/000967 patent/WO2016185242A1/en active Application Filing
- 2015-05-21 JP JP2018512504A patent/JP6684343B2/ja active Active
-
2016
- 2016-05-20 CA CA2986630A patent/CA2986630C/en active Active
- 2016-05-20 DK DK16724409.4T patent/DK3297651T3/da active
- 2016-05-20 WO PCT/EP2016/061488 patent/WO2016185037A1/en active Application Filing
- 2016-05-20 ES ES16724409T patent/ES2792905T3/es active Active
- 2016-05-20 EP EP16724409.4A patent/EP3297651B1/en active Active
- 2016-05-20 US US15/576,027 patent/US10668129B2/en active Active
-
2017
- 2017-11-21 IL IL255816A patent/IL255816B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2986630C (en) | 2021-03-23 |
| JP2018515622A (ja) | 2018-06-14 |
| ES2792905T3 (es) | 2020-11-12 |
| JP6684343B2 (ja) | 2020-04-22 |
| EP3297651A1 (en) | 2018-03-28 |
| IL255816A (en) | 2018-01-31 |
| IL255816B (en) | 2020-08-31 |
| CA2986630A1 (en) | 2016-11-24 |
| WO2016185037A1 (en) | 2016-11-24 |
| US20180153962A1 (en) | 2018-06-07 |
| EP3297651B1 (en) | 2020-02-26 |
| WO2016185242A1 (en) | 2016-11-24 |
| US10668129B2 (en) | 2020-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| DK3872085T3 (da) | Stam-virussekvenser og anvendelser heraf | |
| DK3380101T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3389658T3 (da) | Glycosidasehæmmere og anvendelser deraf | |
| DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3227237T3 (da) | Indretning og anvendelse deraf til uv-bearbejdning af fluider | |
| DK3288553T3 (da) | Kombinationer af cannabinoider og n-acylethanolaminer | |
| DK3364958T3 (da) | Modulatorer af sestrin-gator2-interaktion og anvendelser deraf | |
| DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
| DK3558280T3 (da) | Forebyggelse og behandling af migræne | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3297651T3 (da) | Synergistisk kombination af neuronale levedygtighedsfaktorer og anvendelser deraf | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3269809T3 (da) | MODIFICERET AMINOACYL-tRNA-SYNTETASE OG ANVENDELSE DERAF | |
| DK3384079T3 (da) | Fibrøs konstruktion og fremgangsmåder i forbindelse hermed | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3265126T3 (da) | Kombinationsformulering af tesofensin og metoprolol | |
| DK3417058T3 (da) | Sortase-modificerede molekyler og anvendelser deraf | |
| DK3319759T3 (da) | Skrueværktøj og tilsvarende skrue | |
| DK3316951T3 (da) | Eyewear and flexible elements |